Serum alkaline phosphatase and phosphate in cerebral atherosclerosis and functional outcomes after cerebral infarction

  • Jinkwon Kim
  • , Tae Jin Song
  • , Dongbeom Song
  • , Hye Sun Lee
  • , Chung Mo Nam
  • , Hyo Suk Nam
  • , Young Dae Kim
  • , Ji Hoe Heo

Research output: Contribution to journalArticlepeer-review

52 Scopus citations

Abstract

BACKGROUND AND PURPOSE - Higher serum alkaline phosphatase (ALP) and phosphate levels are associated with atherosclerotic disease and an increased risk of cardiovascular events. However, the association of ALP/phosphate with cerebral atherosclerosis and prognosis in patients with acute stroke is not well known. METHODS - In 1034 patients with first-ever acute cerebral infarction, levels of ALP and phosphate were compared with (1) cerebral atherosclerosis and (2) poor long-term functional outcomes as defined by the modified Rankin Scale >2 at 3 months after stroke onset. RESULTS - ALP levels were not associated with cerebral atherosclerosis. However, higher levels of ALP were associated with a poor functional outcome (adjusted odds ratio per 1 SD, 1.25; 95% confidence interval, 1.04-1.50). Phosphate was associated with neither cerebral atherosclerosis nor functional outcome. CONCLUSIONS - A higher level of ALP was not associated with cerebral atherosclerosis but was an independent prognostic factor for long-term functional outcome after acute cerebral infarction.

Original languageEnglish
Pages (from-to)3547-3549
Number of pages3
JournalStroke
Volume44
Issue number12
DOIs
StatePublished - Dec 2013

Keywords

  • Alkaline phosphatase
  • Atherosclerosis
  • Phosphate
  • Stroke

Fingerprint

Dive into the research topics of 'Serum alkaline phosphatase and phosphate in cerebral atherosclerosis and functional outcomes after cerebral infarction'. Together they form a unique fingerprint.

Cite this